Search research articles
Contact Us
Filters
Showing results (381-390 of 442) with videos related to
Page
of 45
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2022
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)
Malte B Monin, Patrick Ingiliz, Thomas Lutz, et al.
Science Translational Medicine
|
February 18, 2010
Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy
Michelle L Hastings, Joel Berniac, Ying Hsiu Liu, et al.
Neuroepidemiology
|
November 10, 2021
Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke
Monique F Kilkenny, Muideen T Olaiya, Lachlan L Dalli, et al.
The Journal of Antimicrobial Chemotherapy
|
October 21, 2015
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study
Maria Luisa Montes, Mark Nelson, Pierre-Marie Girard, et al.
The Journal of Infection
|
June 6, 2022
Transmission of monkeypox virus through sexual contact - A novel route of infection
Joseph Heskin, Amy Belfield, Charlotte Milne, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure
Sophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2019
Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response
Andrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
The Journal of Infection
|
May 29, 2012
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials
Marcos M Caseiro, Mark Nelson, Ricardo S Diaz, et al.
Lancet (London, England)
|
February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
Jean-Michel Molina, Chloe Orkin, David M Iser, et al.
The Journal of Infection
|
February 2, 2017
Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study
Joseph M Lewis, Colette Smith, Adele Torkington, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 442) with videos related to
Sort By:
Page
of 45
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2022
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)
Malte B Monin, Patrick Ingiliz, Thomas Lutz, et al.
Science Translational Medicine
|
February 18, 2010
Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy
Michelle L Hastings, Joel Berniac, Ying Hsiu Liu, et al.
Neuroepidemiology
|
November 10, 2021
Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke
Monique F Kilkenny, Muideen T Olaiya, Lachlan L Dalli, et al.
The Journal of Antimicrobial Chemotherapy
|
October 21, 2015
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study
Maria Luisa Montes, Mark Nelson, Pierre-Marie Girard, et al.
The Journal of Infection
|
June 6, 2022
Transmission of monkeypox virus through sexual contact - A novel route of infection
Joseph Heskin, Amy Belfield, Charlotte Milne, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure
Sophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2019
Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response
Andrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
The Journal of Infection
|
May 29, 2012
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials
Marcos M Caseiro, Mark Nelson, Ricardo S Diaz, et al.
Lancet (London, England)
|
February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
Jean-Michel Molina, Chloe Orkin, David M Iser, et al.
The Journal of Infection
|
February 2, 2017
Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study
Joseph M Lewis, Colette Smith, Adele Torkington, et al.
Page
of 45